These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 30392753

  • 1. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC.
    Arch Phys Med Rehabil; 2018 Nov; 99(11):2143-2150. PubMed ID: 30392753
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
    Lee J, Yang SN.
    Toxins (Basel); 2024 Apr 19; 16(4):. PubMed ID: 38668622
    [Abstract] [Full Text] [Related]

  • 4. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.
    PLoS One; 2015 Apr 19; 10(6):e0128633. PubMed ID: 26030192
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG.
    Arch Phys Med Rehabil; 2020 Sep 19; 101(9):1485-1496. PubMed ID: 32497599
    [Abstract] [Full Text] [Related]

  • 6. Ultrasonographic Evaluation for the Effect of Extracorporeal Shock Wave Therapy on Gastrocnemius Muscle Spasticity in Patients With Chronic Stroke.
    Lee CH, Lee SH, Yoo JI, Lee SU.
    PM R; 2019 Apr 19; 11(4):363-371. PubMed ID: 30145342
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
    Hokazono A, Etoh S, Jonoshita Y, Kawahira K, Shimodozono M.
    J Hand Ther; 2022 Apr 19; 35(4):507-515. PubMed ID: 33820711
    [Abstract] [Full Text] [Related]

  • 8. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 19; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D, Walcott JM, Jenkins SW, Turkel C, Molloy PT.
    Arch Phys Med Rehabil; 2004 Jul 19; 85(7):1063-9. PubMed ID: 15241751
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effect of focused and radial extracorporeal shock waves on spastic equinus in patients with stroke: a randomized controlled trial.
    Wu YT, Chang CN, Chen YM, Hu GC.
    Eur J Phys Rehabil Med; 2018 Aug 19; 54(4):518-525. PubMed ID: 29072044
    [Abstract] [Full Text] [Related]

  • 11. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV, Da Re C, Messineo I, Bonaiuti D.
    Eur J Phys Rehabil Med; 2015 Aug 19; 51(4):381-7. PubMed ID: 25358636
    [Abstract] [Full Text] [Related]

  • 12. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 13. A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy.
    Mihai EE, Popescu MN, Iliescu AN, Berteanu M.
    Eur J Phys Rehabil Med; 2022 Aug 31; 58(4):565-574. PubMed ID: 35412036
    [Abstract] [Full Text] [Related]

  • 14. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May 31; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 15. Prognosis prediction of the effect of botulinum toxin therapy and intensive rehabilitation on the upper arm function in post-stroke patients using hierarchical cluster analysis.
    Hara T, Niimi M, Yamada N, Shimamoto Y, Masuda G, Hara H, Abo M.
    Disabil Rehabil; 2022 Nov 31; 44(22):6815-6823. PubMed ID: 34547217
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep 31; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extracorporeal Shock Wave Therapy reduces upper limb spasticity and improves motricity in patients with chronic hemiplegia: a case series.
    Troncati F, Paci M, Myftari T, Lombardi B.
    NeuroRehabilitation; 2013 Sep 31; 33(3):399-405. PubMed ID: 23949081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.